Remus Pharmaceuticals fundamental analysis

REMUS

679.95

8.55 (-1.24%)
Last updated on 17 Mar, 2026 | 09:36 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Remus Pharmaceuticals Fundamentals

P/E Ratio

27.91

P/B Ratio

3.1

Div. Yield

0.11

Sector P/E

37.18

Sector P/B

1.89

Sec. Div. Yield

82.35

Remus Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 27.91, compared to the sector average of 37.18. Its P/B Ratio stands at 3.1, while the sector’s is 1.89. In terms of returns, the stock offers a Dividend Yield of 0.11%, which is than the sector’s 82.35%.

Remus Pharmaceuticals Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Remus Pharmaceuticals reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost